CD4 and myeloid sarcoma: Despite conflicting findings regarding abundance, circulating CD56bright NK cells from MS patients have reduced IFN-γ production in response to IL-12 and an impaired ability to regulate autologous CD4+ T cells compared to healthy controls (33, 35).